Original Article
Original Article
/ VOLUME 4, ISSUE 1, MARCH 2022
Pınar Korkmaz and others
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. It spread rapidly, resulting in a pandemic throughout the world. In February 2020, the World Health Organization (WHO) named the disease COVID-19. Studies reported that COVID-19 mostly progressed with asymptomatic (...) Read More
Original Article
/ VOLUME 4, ISSUE 1, MARCH 2022
Derya Yapar and others
The number of cases of coronavirus disease 2019 (COVID-19) continues to threaten the world by increasing day by day. COVID-19 primarily affects the respiratory system and the most common clinical symptoms are fever, cough (...) Read More
Original Article
/ VOLUME 4, ISSUE 1, MARCH 2022
Mehmet Kürşat Bilgin and others
Fungal infections account for about 20% of all microbiological infections in critically ill patients. Candida species are the most common fungi in intensive care units (ICU) and mostly C. albicans. However, the rate of non-albicans Candida species such as C. tropicalis, C. krusei, C. parapsilosis, C. glabrata which are more resistant to antifungal therapy (...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Kayıhan Pala and others
Estimations about confirmed COVID-19 deaths may be limited to the testing capacity and frequency, along with correct and complete reporting of the cause of deaths (1). The number of confirmed and probable COVID-19 deaths may not include people who (...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Oya Özlem Eren-Kutsoylu and others
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the disease called the coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020, and on the same day, the Republic of Turkey (...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Sevil Alkan-Çeviker and others
Coronavirus disease 2019 (COVID-19) was declined as a pandemic by the World Health Organization (WHO) in March 2020. The initial diagnosis of the disease was made in a very complex process. In addition to treating and preventing its spread, vaccination (...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Yeşim Tuyji-Tok and others
Hepatitis C virus (HCV), defined as a non-A non-B hepatitis agent in 1989, is a hepatotropic, noncytopathic, positive-stranded ribonucleic acid (RNA) virus from the family Flaviviridae. HCV infection is an acute or chronic necroinflammatory (...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Aziz Ahmad Hamidi and Serhat Kescioğlu
The Crimean-Congo hemorrhagic fever (CCHF) is caused by a RNA virus (Nairovirus) Bunyaviridae family. It is generally transmitted by tick bite (Hyalomma marginatum), particularly in spring and summer, and the blood (...= Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Elif Mukime Sarıcaoğlu and others
Influenza constitutes one of the major threats to the health system, affecting up to 10% of the world’s population every year. According to the Centers for Disease Control and Prevention (CDC) database, between 1999-2015, 291,000-646,000 deaths caused by influenza-associated respiratory disease(...) Read More
Original Article
/ VOLUME 3, ISSUE 3, DECEMBER 2021
Özlem Doğan and others
Biofilm formation is one of the most important virulence factors for Candida species. Biofilm can be defined as a whole microbial community formed by microorganisms (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Mehmet Yıldız and others
The COVID-19 pandemic emerged in Wuhan in December 2019 and spread rapidly all over the world. The number of cases worldwide reached a total of 150 million as of May 2021. While 14% of these cases required hospitalization with severe pneumonia (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Derya Yapar and others
Diabetes is a widespread metabolic disease in the world. Diabetic foot, which develops in cases where diabetes control is not provided, is a clinical picture that impairs the quality of life of cases and sometimes leads to undesirable consequences including limb amputation. The global prevalence (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Asiye Bahar Kaçmaz and others
The SARS-CoV-2 infection has influenced the whole world and every day, both the number of cases and deaths related to the COVID-19 pandemic continue to rise. Eighty-one percent of COVID-19 cases are mild, 14% are serious and 5% are critical. Although the overall mortality rate was 2.3%, mortality (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Mahir Kapmaz and others
The clinical findings of SARS-CoV-2 infection are heterogeneous, and the duration of viral RNA shedding varies on the age of the patient, severity of the disease, and type of the sample. For that reason, a comprehensive analysis of the dynamics of viral shedding is critical for (...) Read More
Original Article
/ VOLUME 3, ISSUE 2, AUGUST 2021
Çiğdem Erol and others
SARS-CoV-2 is transmitted via the inhalation of infected droplets or through direct contact with contaminated surfaces. Aerosol-generating procedures can also lead to airborne transmission. Healthcare workers (HCWs) are at higher risks for infections than the general (...) Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Serap Şimşek-Yavuz and others
Infective endocarditis (IE), among the most common life-threatening infection, is a serious disease causing substantial morbidity and mortality. Determining at-risk patients and following them up closely with appropriate interventions are necessary to decrease complications and mortality. Treatment response to infective endocarditis is followed up with the combination of relief of symptoms, blood cultures, echocardiographic investigations and laboratory tests. A simple and widely available test Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Şiran Keske and others
Healthcare-associated infections (HAI) is an increasing global problem all over the world. Multidrug-resistant (MDR) pathogens, including carbapenem-resistant Gram-negative Enterobacterales, Pseudomonas spp. and Acinetobacter spp. have become common causes of HAI, such as central line-associated bloodstream infections (BSIs), catheter-associated urinary tract infections (UTIs), surgical site infections (SSIs) and ventilatory associated pneumonia (VAPs). These infections increase not only mortality but also healthcare Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Aral Sürmeli and others
Introduction The novel coronavirus (SARS-CoV-2) started in December 2019 in China, has infected over 4.2 million people worldwide, resulting in a death toll of 290 000 as of 13 May 2020 (1). It causes a multi-systemic infection named Coronavirus Disease 2019 (COVID-19). The symptoms reported are Read More
Original Article
/ VOLUME 3, ISSUE 1, APRIL 2021
Oğuz Evlice and others
Introduction More than a year has passed since the beginning of the COVID-19 pandemic, and we are learning more about the long-term effects of the disease. While many patients recover completely, some continue to experience fatigue, dyspnea, cough, joint pain, and chest pain for weeks or even months (1).The UK National Institute for Health and […] Read More
Original Article
/ VOLUME 2, ISSUE 3, DECEMBER 2020
Mehtap Aydın and others
Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More